Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566668 · ClinicalTrials.gov registry record
Immune Interactions in Severe Asthma
A clinical trial of Asthma, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 115
- Enrollment target
- 1
- Study location
NCT02566668 is a study of Asthma that has completed, run by University of Pittsburgh. The registered enrollment target is 115 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02566668, a study of Asthma, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is being done to learn more about severe asthma by comparing people with severe asthma to those with milder forms of asthma and people without asthma, at baseline and over time. Individuals are being asked to join a research study to help understand the differences in the lungs and blood of participants with severe asthma compared to those with milder asthma and healthy individuals, as well as differences in overall health. Investigators also want to determine whether these differences predict asthma-related and biologic outcomes over 1 year of follow up.
Conditions Studied
Interventions
- OTHER 1 year Observational Follow-up
Study Locations (1)
Pennsylvania
- University of Pittsburgh Asthma Institute at UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2015-09 |
| Est. Completion | 2024-08-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02566668
The ClinicalTrials.gov registry entry for NCT02566668 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which 1 year Observational Follow-up is the first listed.
NCT02566668 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02566668 about?
NCT02566668 is a clinical study titled "Immune Interactions in Severe Asthma". This research study is being done to learn more about severe asthma by comparing people with severe asthma to those with milder forms of asthma and people without asthma, at baseline and over time. Individuals are being asked to join a research study to help understand the differences in the lungs a...
What is the current status of trial NCT02566668?
This trial is currently completed. The enrollment target is 115 participants. The study started on 2015-09. Estimated completion is 2024-08-22.
What conditions does trial NCT02566668 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT02566668?
The interventions under investigation include: 1 year Observational Follow-up (OTHER).
Who is sponsoring clinical trial NCT02566668?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02566668 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.